Skip to content

TO ASSESS AND COMPARE EFFECT OF HOMOEOPATHIC MOTHER TINCTURES GYMNEMA SYLVESTRE AND CEPHALANDRA INDICA ON BLOOD SUGAR LEVELS IN TYPE 2 DIABETES MELLITUS

A COMPARATIVE STUDY OF GYMNEMA SYLVESTRE Q AND CEPHALENDRA INDICA Q ON BLOOD SUGAR LEVELS IN DIABETES MELLITUS TYPE 2 ALONG WITH CONVENTIONAL ANTIDIABETES - NO

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/02/049426
Enrollment
30
Registered
2023-02-03
Start date
Unknown
Completion date
Unknown
Last updated
2023-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: Gymnema Sylvestre Q : Gymnema Sylvestre Q will be administered in liquid form on 15 patients. Minimum 10 drops of Tincture will be diluted in distilled water and will be given thrice a

Sponsors

Dr Pooja Prakash Liman
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients who fulfill case definition will be considered 2.Both sexes male and female 3.Patients of age group 45 to 65 years. 4.Patients with known case of diabetes mellitus who are on conventional anti-diabetic treatment with HBA1C >6.5%. 5.BSL fasting >126 mg/dl ; postprandial >200mg/dl

Exclusion criteria

Exclusion criteria: 1.Patients suffering from life threatening diseases and those who need emergency medical interventions. 2.Patients with any severe concomitant illness like Polyneuropathy, Cardio-vascular diseases, Retinopathy, nephropathy, kidney failure, Diabetic Ketoacidosis, who may not be able to come for regular follow -ups, will not be considered. 3.Any patient with gross neurological-neuropathy defects. 4.Patients with any major systemic illness.

Design outcomes

Primary

MeasureTime frame
Assessment of Cephalendra indica Q and Gymnema sylvestre Q on blood sugar level in type 2 diabetes mellitus.Timepoint: 1. Haematological examination (fasting blood sugar and postpranidial and HBA1C) will be done in every 15 days to assess and compare effect of homoeopathic mother tinctures in DMT2 patients in duration of 3 months 2. Symptomatic changes

Secondary

MeasureTime frame
â?¢ To know possible effective of Cephalendra indica Q in DMT2 patients. â?¢ To know possible effective of Gymnema sylvestre Q in DMT2 patients. â?¢ To control blood sugar levels and HBA1C levels to prevent complications of diabetes mellitus Timepoint: 1. Haematological examination (fasting blood sugar and postpranidial and HBA1C) will be done in every 15 days to assess and compare effect of homoeopathic mother tinctures in DMT2 patients in duration of 3 months 2. Symptomatic changes

Countries

India

Contacts

Public ContactDR POOJA PRAKASH LIMAN

B.V.D.U.Homoeopathic Medical College and Hospital, Dept of Post Graduate and Research Centre

mrinalnerlekar@gmail.com9422321397

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026